Advertisement

Annals of Clinical Psychiatry

, Volume 15, Issue 3–4, pp 233–239 | Cite as

Atypical Antipsychotics in the Treatment of Delusional Parasitosis

  • Michael T. Wenning
  • Leigh E. Davy
  • Glenn CatalanoEmail author
  • Maria C. Catalano
Case Law Studies

Abstract

Delusional parasitosis is the false belief that one's body is infested with one or many different living organisms. Historically, it has been treated with conventional antipsychotics with only moderate success. The conventional antipsychotic most commonly used has been pimozide. We report a series of five cases of patients with delusional parasitosis. Our patients' demographic characteristics were similar to those in previously published case reports, but instead of being treated with older antipsychotics, they were all treated with atypical antipsychotic agents with favorable results. We will discuss the rationale for this treatment choice, and will review the role of serotonin/dopamine antagonists in the treatment of delusional parasitosis. We will also comment on the possible role of serotonergic antidepressants in the treatment of these patients.

delusional parasitosis pimozide atypical antipsychotics serotonin dopamine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Munro A: Monosymptomatic hypochondriacal psychosis. Br J Hosp Med 1980; 24:34-38Google Scholar
  2. 2.
    Koo JYM, Gambla G: Psychodermatology: Delusions of parasitosis and other forms of monosymptomatic hypochondriacal psychosis; general discussion and case illustrations. Dermatol Clin 1996; 14(3):429-438Google Scholar
  3. 3.
    Bhatia M, Jagawat T, Choudhary S: Delusional parasitosis: A clinical profile. Int J Psychiatry Med 2000; 30(1):83-91Google Scholar
  4. 4.
    American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edn., text rev. Washington, DC: American Psychiatric Association; 2000:323-329Google Scholar
  5. 5.
    Reilly TM, Batchelor DH: The presentation and treatment of delusional parasitosis: A dermatologic perspective. Int Clin Psychopharmacol 1986; 1:340-353Google Scholar
  6. 6.
    Wykoff RF: Delusions of parasitosis: A review. Rev Infect Dis 1987; 9:433-437Google Scholar
  7. 7.
    Lell A: The Michelson lecture, delusion of parasitosis. Br J Dermatol 1983; 108:485-499Google Scholar
  8. 8.
    Trabert W: Shared psychotic disorder in delusional parasitosis. Psychopathology 1999; 32:30-34Google Scholar
  9. 9.
    Trabert W: 100 years of delusional parasitosis. Psychopathology 1995; 28:238-246Google Scholar
  10. 10.
    Berrios GE: Delusional parasitosis and physical disease. Compr Psychiatry 1985; 26:395-403Google Scholar
  11. 11.
    Baker PB, Cook BI, Winokur G: Delusional infestation. Psychiatr Clin North Am 1995; 18:345-361Google Scholar
  12. 12.
    May WW, Terpenning MS: Delusional parasitosis in geriatric patients. Psychosomatics 1991; 32:88-94Google Scholar
  13. 13.
    Musalek M, Bach M, Passweg V, Jaeger S: The position of delusional parasitosis in psychiatric nosology and classification. Psychopathology 1990; 23:115-124Google Scholar
  14. 14.
    Rasanen P, Erkonen K, Isaksson U, Koiio P, Varis R, Timonen M, Leinonen E, Isohanni M, Alanko A: Delusional parasitosis in the elderly: A review and report of six cases from northern Finland. Int Psychogeriatr 1997; 9(4):459-464Google Scholar
  15. 15.
    Zomer SF, De Wit RF, Van Bonswijik JE, Nabarro G, Van Vloten WA: Delusions of parasitosis: A psychiatric disorder to be treated by dermatologists? An analysis of 33 patients. Br J Dermatol 1998; 138:1030-1032Google Scholar
  16. 16.
    Richelson E: Receptor pharmacology and neuroleptics: Relation to clinical effects. J Clin Psychiatry 1999; 60:5-14Google Scholar
  17. 17.
    Elmer KB, Georg RM, Peterson K: Therapeutic update: Use of risperidone for the treatment of monosymptomatic hypochondriacal psychosis. J Am Acad Dermatol 2000; 43:683-686Google Scholar
  18. 18.
    Riding BE, Munro A: Pimozide in monosymptomatic delusional parasitosis. Lancet 1975; 1:400-401Google Scholar
  19. 19.
    Monro A, Mok H: An overview of treatment in paranoia/delusional disorder. Can J Psychiatry 1995; 40:616-622Google Scholar
  20. 20.
    Hanumantha K, Pradhan PV, Suvarna B: Delusional parasitosis—Study of 3 cases. J Postgrad Med 1994; 40:222-224Google Scholar
  21. 21.
    Johnson GC, Anton RF: Pimozide in delusions of parasitosis. J Clin Psychiatry 1983; 44:233Google Scholar
  22. 22.
    King BH: Hypothesis: Involvement of the serotonergic system in the clinical expression of monosymptomatic hypochondriasis. Pharmacopsychiatry 1990; 23:85-89Google Scholar
  23. 23.
    DeLeon OA, Furmaga KM, Canterbury AL, Baily LG: Risper-done in the treatment of delusions of infestation. Int J Psychiatry Med 1997; 27:403-409Google Scholar
  24. 24.
    Kitamura H: A case of somatic delusional disorder that responded to treatment with risperidone Psychiatry Clin Neurosci 1997; 51(5):337Google Scholar
  25. 25.
    Songer DA, Roamn B: Treatment of somatic delusional disorder with atypical antipsychotic agents. Am J Psychiatry 1996; 153:578-579Google Scholar
  26. 26.
    Heym J, Jacobs BL: Serotonergic mechanisms of hallucinogenic drug effects. Monogr Neural Sci 1987; 13:55-81Google Scholar
  27. 27.
    Driscoll MS, Rothe MJ, Grant-Kels JM, Hale MS: Delusional parasitosis: A dermatologic, psychiatric, and pharmacologic approach. J Am Acad Dermatol 1993; 29:1023-1033Google Scholar
  28. 28.
    Peroutka SJ, Snyder SH: Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 1980; 137(12):1518-1522Google Scholar
  29. 29.
    Bymaster FP: In vitro and in vivo biochemistry of olanzapine. J Clin Psychiatry 1997; 15(2):10-12Google Scholar
  30. 30.
    McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH: A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibition-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2000; 57:794-801Google Scholar
  31. 31.
    Stein DJ, Bouwer MB, Hawkridge S, Emsley RA: Risperdone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. J Clin Psychiatry 1997; 58:119-122Google Scholar

Copyright information

© American Academy of Clinical Psychiatrists 2003

Authors and Affiliations

  • Michael T. Wenning
    • 1
  • Leigh E. Davy
    • 1
  • Glenn Catalano
    • 1
    Email author
  • Maria C. Catalano
    • 2
  1. 1.Department of Psychiatry and Behavioral MedicineUniversity of South Florida College of MedicineTampa
  2. 2.Psychiatry ServiceJames A. Haley Veterans' HospitalTampa

Personalised recommendations